MediPress Health (Israel) Performance

MPRS Stock   71.80  0.00  0.00%   
The company secures a Beta (Market Risk) of 0.1, which conveys not very significant fluctuations relative to the market. As returns on the market increase, MediPress Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding MediPress Health is expected to be smaller as well. At this point, MediPress Health Lim has a negative expected return of -0.2%. Please make sure to verify MediPress Health's variance, jensen alpha, and the relationship between the standard deviation and information ratio , to decide if MediPress Health Lim performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MediPress Health Limited Partnership has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors. ...more
  

MediPress Health Relative Risk vs. Return Landscape

If you would invest  7,910  in MediPress Health Limited Partnership on August 25, 2024 and sell it today you would lose (730.00) from holding MediPress Health Limited Partnership or give up 9.23% of portfolio value over 90 days. MediPress Health Limited Partnership is generating negative expected returns and assumes 1.6478% volatility on return distribution over the 90 days horizon. Simply put, 14% of stocks are less volatile than MediPress, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon MediPress Health is expected to under-perform the market. In addition to that, the company is 2.14 times more volatile than its market benchmark. It trades about -0.12 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.15 per unit of volatility.

MediPress Health Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for MediPress Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as MediPress Health Limited Partnership, and traders can use it to determine the average amount a MediPress Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.1195

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsMPRS

Estimated Market Risk

 1.65
  actual daily
14
86% of assets are more volatile

Expected Return

 -0.2
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.12
  actual daily
0
Most of other assets perform better
Based on monthly moving average MediPress Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MediPress Health by adding MediPress Health to a well-diversified portfolio.

MediPress Health Fundamentals Growth

MediPress Stock prices reflect investors' perceptions of the future prospects and financial health of MediPress Health, and MediPress Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on MediPress Stock performance.

About MediPress Health Performance

By analyzing MediPress Health's fundamental ratios, stakeholders can gain valuable insights into MediPress Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if MediPress Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if MediPress Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.

Things to note about MediPress Health Lim performance evaluation

Checking the ongoing alerts about MediPress Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for MediPress Health Lim help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
MediPress Health Lim generated a negative expected return over the last 90 days
About 28.0% of the company outstanding shares are owned by corporate insiders
Evaluating MediPress Health's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate MediPress Health's stock performance include:
  • Analyzing MediPress Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether MediPress Health's stock is overvalued or undervalued compared to its peers.
  • Examining MediPress Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating MediPress Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of MediPress Health's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of MediPress Health's stock. These opinions can provide insight into MediPress Health's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating MediPress Health's stock performance is not an exact science, and many factors can impact MediPress Health's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for MediPress Stock analysis

When running MediPress Health's price analysis, check to measure MediPress Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MediPress Health is operating at the current time. Most of MediPress Health's value examination focuses on studying past and present price action to predict the probability of MediPress Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MediPress Health's price. Additionally, you may evaluate how the addition of MediPress Health to your portfolios can decrease your overall portfolio volatility.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency